Field dependence of the electronic phase separation in Pr0.67Ca0.33MnO3 by small angle magnetic neutron scattering

We have studied by small angle neutron scattering the evolution induced by the application of magnetic field of the coexistence of ferromagnetism (F) and antiferromagnetism (AF) in a crystal of Pr$_{0.67}$Ca$_{0.33}$MnO$_3$. The results are compared to magnetic measurements which provide the evolution of the ferromagnetic fraction. These results show that the growth of the ferromagnetic phase corresponds to an increase of the thickness of the ferromagnetic ''cabbage'' sheets

Scaling property and peculiar velocity of global monopoles

We investigate the scaling property of global monopoles in the expanding universe. By directly solving the equations of motion for scalar fields, we follow the time development of the number density of global monopoles in the radiation dominated (RD) universe and the matter dominated (MD) universe. It is confirmed that the global monopole network relaxes into the scaling regime and the number per hubble volume is a constant irrespective of the cosmic time. The number density $n(t)$ of global monopoles is given by $n(t) \simeq (0.43\pm0.07) / t^{3}$ during the RD era and $n(t) \simeq (0.25\pm0.05) / t^{3}$ during the MD era. We also examine the peculiar velocity $v$ of global monopoles. For this purpose, we establish a method to measure the peculiar velocity by use of only the local quantities of the scalar fields. It is found that $v \sim (1.0 \pm 0.3)$ during the RD era and $v \sim (0.8 \pm 0.3)$ during the MD era. By use of it, a more accurate analytic estimate for the number density of global monopoles is obtained.Comment: 17 pages, 8 figures, to appear in Phys. Rev.

Coulomb-nuclear interference in the breakup of 11^{11}Be

Within a theory of breakup reactions formulated in the framework of the post form distorted wave Born approximation, we calculate contributions of the pure Coulomb and the pure nuclear breakup as well as those of their interference terms to a variety of cross sections in breakup reactions of the one-neutron halo nucleus $^{11}$Be on a number of target nuclei. In contrast to the assumption often made, the Coulomb-nuclear interference terms are found to be non-negligible in case of exclusive cross sections of the fragments emitted in this reaction on medium mass and heavy target nuclei. The consideration of the nuclear breakup leads to a better description of such data.Comment: 9 pages, latex, 2 figures, to be published in Phys. Rev. C (Rapid Communication

Alkaline phosphatase for treatment of sepsis-induced acute kidney injury: a prospective randomized double-blind placebo-controlled trial

Introduction: To evaluate whether alkaline phosphatase (AP) treatment improves renal function in sepsis-induced acute kidney injury (AKI), a prospective, double-blind, randomized, placebo-controlled study in critically ill patients with severe sepsis or septic shock with evidence of AKI was performed.Methods: Thirty-six adult patients with severe sepsis or septic shock according to Systemic Inflammatory Response Syndrome criteria and renal injury defined according to the AKI Network criteria were included. Dialysis intervention was standardized according to Acute Dialysis Quality Initiative consensus. Intravenous infusion of alkaline phosphatase (bolus injection of 67.5 U/kg body weight followed by continuous infusion of 132.5 U/kg/24 h for 48 hours, or placebo) starting within 48 hours of AKI onset and followed up to 28 days post-treatment. The primary outcome variable was progress in renal function variables (endogenous creatinine clearance, requirement and duration of renal replacement therapy, RRT) after 28 days. The secondary outcome variables included changes in circulating inflammatory mediators, urinary excretion of biomarkers of tubular injury, and safety.Results: There was a significant (P = 0.02) difference in favor of AP treatment relative to controls for the primary outcome variable. Individual renal parameters showed that endogenous creatinine clearance (baseline to Day 28) was significantly higher in the treated group relative to placebo (from 50 ± 27 to 108 ± 73 mL/minute (mean ± SEM) for the AP group; and from 40 ± 37 to 65 ± 30 mL/minute for placebo; P = 0.01). Reductions in RRT requirement and duration did not reach significance. The results in renal parameters were supported by significantly more pronounced reductions in the systemic markers C-reactive protein, Interleukin-6, LPS-binding protein and in the urinary excretion of Kidney Injury Molecule-1 and Interleukin-18 in AP-treated patients relative to placebo. The Drug Safety Monitoring Board did not raise any issues throughout the trial.Conclusions: The improvements in renal function suggest alkaline phosphatase is a promising new treatment for patients with severe sepsis or septic shock with AKI.Trial Registration: www.clinicaltrials.gov: NCTNCT00511186. © 2012 Pickkers et al.; licensee BioMed Central Ltd

High CD33-antigen loads in peripheral blood limit the efficacy of gemtuzumab ozogamicin |(Mylotarg®) treatment in acute myeloid leukemia patients

Gemtuzumab ozogamicin (Mylotarg®) induces remission in approximately 30% of relapsed AML patients. We previously demonstrated that gemtuzumab infusion results in near-complete CD33 saturation in peripheral blood, and that saturating gemtuzumab levels result in continuous binding and internalization of gemtuzumab due to renewed CD33 expression. We now demonstrate that a high CD33-antigen load in peripheral blood is an independent adverse prognostic factor, likely due to peripheral consumption of gemtuzumab. Indeed, CD33 saturation in bone marrow is significantly reduced (40-90% saturation) as compared with CD33 saturation in corresponding peripheral blood samples (>90%). In vitro, such reduced CD33 saturation levels were strongly related with reduced cell kill. Apparently, high CD33-antigen loads in blood consume gemtuzumab and thereby limit its penetration into bone marrow. Consequently, CD33 saturation in bone marrow is reduced, which hampers efficient cell kill. Therefore, gemtuzumab should be administered at higher or repeated doses, or, preferably, after reduction of the leukemic cell burden by classical chemotherapy

Cosmological Evolution of Global Monopoles

We investigate the cosmological evolution of global monopoles in the radiation dominated (RD) and matter dominated (MD) universes by numerically solving field equations of scalar fields. It is shown that the global monopole network relaxes into the scaling regime, unlike the gauge monopole network. The number density of global monopoles is given by $n(t) \simeq (0.43\pm0.07) / t^{3}$ during the RD era and $n(t) \simeq (0.25\pm0.05) / t^{3}$ during the MD era. Thus, we have confirmed that density fluctuations produced by global monopoles become scale invariant and are given by $\delta \rho \sim 7.2(5.0) \sigma^{2} / t^{2}$ during the RD (MD) era, where $\sigma$ is the breaking scale of the symmetry.Comment: 6 pages, 2 figures, to appear in Phys. Rev. D (R

Health behaviours of Australian men and the likelihood of attending a dedicated men's health service

Background: Redesigning primary health services may enhance timely and effective uptake by men. The primary aim of this study was to assess the likelihood of Australian men attending a dedicated men's health service (DMHS). The further aims were to better understand the reasons for their preferences and determine how health behaviours influence likelihood. Methods: A survey on health service use and preferences, health help-seeking behaviours, and the likelihood of attending a DMHS was administered by telephone to 1506 randomly selected men (median age 56 years, range 19-95). Likelihood of attending a DMHS was rated using a single item Likert scale where 0 was not at all likely and 10 highly likely. Respondents were classified by age ( = 65 years) and health status. Principal component analyses were used to define health behaviours, specifically help-seeking and delay/avoidance regarding visiting a doctor. Multivariable linear and logistic regression analyses were used to examine predictors of likelihood of attending a DMHS. Results: The mean likelihood of attending a DMHS was 5.8 (SD 3.3, median 6, moderate likelihood) and 21%, 26% and 23% of men rated likelihood as moderate, high and very high respectively. Being happy with their existing doctor was the most common reason (52%) for being less likely to attend a DMHS. In unadjusted analyses, younger men reported being more likely to attend a DMHS (p < 0.001) with older-sick men reporting being least likely (p < 0.001). Younger men were more likely than older men to score higher on delay/avoidance and were more likely to self-monitor. In the full model, men with current health concerns (p ≤ 0.01), who scored higher on delay/avoidance (p ≤ 0.0006), who were more likely to be information-seekers (p < 0.0001) and/or were motivated to change their health (p ≤ 0.0001) reported a higher likelihood of attending a DMHS irrespective of age and health status. Conclusions: Seventy percent of men reported a moderate or higher likelihood of attending a DMHS. As young healthy men are more likely than older men to display health behaviours that are associated with a higher likelihood of attending a DHMS, such as delay/avoidance, marketing a DMHS to such men may be of value.Andrew D. Vincent, Phoebe G. Drioli-Phillips, Jana Le, Lynette Cusack, Timothy J. Schultz, Margaret A. McGee, Deborah A. Turnbull, and Gary A. Witter